Mindoo raises €5m for hospital AI automation

By Published On: December 16, 2025
Mindoo raises €5m for hospital AI automation

Antwerp’s Mindoo has raised €5m seed funding to expand its hospital AI agents that handle routine tasks and ease workload.

Mindoo builds “agentic” workflows, meaning software agents that follow set rules to complete tasks such as intake, documentation and follow-up, with controls for safety and oversight.

The platform offers four configurable agents for reception, pre-visit intake, clinical scribing and post-visit follow-up. Hospitals can tailor them to local protocols, specialities and languages.

Mindoo is already in use in hospitals in Belgium and Germany and integrates with electronic health record systems. Expansion to the Netherlands and France is planned as new reference sites go live.

Founded in 2025, the company says its tools help organisations handle rising demand without adding headcount by automating structured, repeatable work.

“We learned very quickly that workflows in healthcare cannot be adapted to a product. The product has to adapt to existing workflows.” said Gauthier Willemse, chief executive and co-founder.
“That is why Mindoo lets hospital teams configure and run their own agents, so automation fits naturally into how they already work.”

“We designed Mindoo so healthcare organisations can deploy agents that follow their rules, integrate with their systems and behave predictably in real-world environments.” said Bart Lens, chief technology officer and co-founder.
“This is how AI becomes operational, not experimental.”

The seed round was raised from 6DC, Syndicate One and strategic angel investors.

“We invested in Mindoo because the founders understand healthcare from the inside and have built a platform that lets hospitals adopt AI responsibly. The opportunity ahead is enormous. Automated workflows will become essential infrastructure for healthcare.” said Lucas Stoops, partner at 6 Degrees Capital.

Yellow wristbands launched to help locate people with dementia
Sanofi and ADEL sign US$1.04bn Alzheimer’s deal